{"transactions":[{"id":1222243,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T16:30:17.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":2407,"price":76.43,"value":183967.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction pursuant to the terms of the RSU award."}],"balance_after":36042,"source":{"system":"sec-edgar","filing":"0000950170-25-033706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017025033706/ownership.xml","form_type":"4"}},{"id":1242777,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T18:07:19.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":26499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service."}],"balance_after":26499,"derivative":{"exercise_price":77.12,"expiration_date":"2035-02-24","underlying":"Common Stock","underlying_shares":26499},"source":{"system":"sec-edgar","filing":"0000950170-25-028040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017025028040/ownership.xml","form_type":"4"}},{"id":1242776,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-26T18:07:19.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":17606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 17,606 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":38449,"source":{"system":"sec-edgar","filing":"0000950170-25-028040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017025028040/ownership.xml","form_type":"4"}},{"id":1305067,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-10T16:29:36.000Z","date":"2025-01-07","kind":"exercise","planned":true,"acquired":false,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":15167,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0000950170-25-004192","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017025004192/ownership.xml","form_type":"4"}},{"id":1305066,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-10T16:29:36.000Z","date":"2025-01-07","kind":"sale","planned":true,"acquired":false,"shares":1083,"price":80.05,"value":86694.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-25-004192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017025004192/ownership.xml","form_type":"4"}},{"id":1305065,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-10T16:29:36.000Z","date":"2025-01-07","kind":"exercise","planned":true,"acquired":true,"shares":1083,"price":13.28,"value":14382.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":21926,"source":{"system":"sec-edgar","filing":"0000950170-25-004192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017025004192/ownership.xml","form_type":"4"}},{"id":1342797,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T18:00:03.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":1084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":16250,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1084},"source":{"system":"sec-edgar","filing":"0000950170-24-133392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024133392/ownership.xml","form_type":"4"}},{"id":1342796,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T18:00:03.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":1084,"price":86.4,"value":93657.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $86.21 to $86.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-133392","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024133392/ownership.xml","form_type":"4"}},{"id":1342795,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T18:00:03.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":1084,"price":13.28,"value":14395.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":21927,"source":{"system":"sec-edgar","filing":"0000950170-24-133392","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024133392/ownership.xml","form_type":"4"}},{"id":1366446,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-13T16:30:15.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":false,"shares":1458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":5834,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":1458},"source":{"system":"sec-edgar","filing":"0000950170-24-126397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024126397/ownership.xml","form_type":"4"}},{"id":1366445,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-13T16:30:15.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":1458,"price":90.04,"value":131278.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-126397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024126397/ownership.xml","form_type":"4"}},{"id":1366444,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-13T16:30:15.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":true,"shares":1458,"price":38.46,"value":56074.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22301,"source":{"system":"sec-edgar","filing":"0000950170-24-126397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024126397/ownership.xml","form_type":"4"}},{"id":1375279,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-05T16:30:09.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":false,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":17334,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0000950170-24-121525","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024121525/ownership.xml","form_type":"4"}},{"id":1375278,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-05T16:30:09.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":1083,"price":82.64,"value":89499.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.55 to $82.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-121525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024121525/ownership.xml","form_type":"4"}},{"id":1375277,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-05T16:30:09.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":true,"shares":1083,"price":13.28,"value":14382.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":21926,"source":{"system":"sec-edgar","filing":"0000950170-24-121525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024121525/ownership.xml","form_type":"4"}},{"id":1391827,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":18417,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391826,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027."}],"balance_after":12098,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391825,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":1458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":7292,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":1458},"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391824,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":134,"price":154.86,"value":20751.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $154.785 to $154.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391823,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":20,"price":153.75,"value":3075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":20977,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391822,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":80,"price":152.28,"value":12182.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":20997,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391821,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":80,"price":151.2,"value":12096.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":21077,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391820,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":318,"price":150.38,"value":47820.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.07 to $150.555, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21157,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391819,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":523,"price":149.59,"value":78235.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.06 to $150.005, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21475,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391818,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":80,"price":147.98,"value":11838.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":21998,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391817,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":900,"price":146.9,"value":132210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $146.555 to $147.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22078,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391816,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":823,"price":146.15,"value":120281.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $145.54 to $146.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22978,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391815,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":1083,"price":13.28,"value":14382.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":23801,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391814,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":66.1,"value":27563.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22718,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1391813,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-03T16:30:08.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":1458,"price":38.46,"value":56074.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22301,"source":{"system":"sec-edgar","filing":"0000950170-24-112394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024112394/ownership.xml","form_type":"4"}},{"id":1413786,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":1084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":19500,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1084},"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413785,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027."}],"balance_after":12515,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413784,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":1459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":8750,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":1459},"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413783,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":165.87,"value":16587.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413782,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":32,"price":164.68,"value":5269.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $164.60 to $164.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20943,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413781,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":80,"price":163.09,"value":13047.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $162.55 to $163.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20975,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413780,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":700,"price":161.54,"value":113078.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $161.21 to $161.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21055,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413779,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":396,"price":160.67,"value":63625.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $160.19 to $161.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21755,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413778,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":132,"price":159.02,"value":20990.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $158.85 to $159.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22151,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413777,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":921,"price":158.09,"value":145600.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $157.83 to $158.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22283,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413776,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":599,"price":157.27,"value":94204.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $156.82 to $157.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23204,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413775,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":1084,"price":13.28,"value":14395.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":23803,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413774,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":66.1,"value":27563.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22719,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1413773,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:30:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":1459,"price":38.46,"value":56113.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22302,"source":{"system":"sec-edgar","filing":"0000950170-24-104046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024104046/ownership.xml","form_type":"4"}},{"id":1440606,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":20584,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440605,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027."}],"balance_after":12932,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440604,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":1458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":10209,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":1458},"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440603,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":14,"price":166,"value":2324.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440602,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":84,"price":164.98,"value":13858.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $164.80 to $165.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20857,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440601,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":32,"price":163.65,"value":5236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $163.28 to $164.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20941,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440600,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":116,"price":161.99,"value":18790.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $161.67 to $162.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20973,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440599,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":126,"price":161.09,"value":20297.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $160.63 to $161.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21089,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440598,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":329,"price":159.86,"value":52593.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $159.47 to $160.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21215,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440597,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":240,"price":158.88,"value":38131.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $158.39 to $159.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21544,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440596,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":252,"price":157.83,"value":39773.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $157.39 to $158.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21784,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440595,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":124,"price":157,"value":19468.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $156.29 to $157.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22036,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440594,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":380,"price":155.69,"value":59162.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $155.28 to $156.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22160,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440593,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":510,"price":154.86,"value":78978.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $154.27 to $155.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22540,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440592,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":483,"price":153.81,"value":74290.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $153.24 to $154.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23050,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440591,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":154,"price":152.71,"value":23517.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $152.20 to $153.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23533,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440590,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":114,"price":151.8,"value":17305.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.19 to $152.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23687,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440589,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":1083,"price":13.28,"value":14382.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":23801,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440588,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":66.1,"value":27563.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22718,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1440587,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-05T18:08:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":1458,"price":38.46,"value":56074.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22301,"source":{"system":"sec-edgar","filing":"0000950170-24-091017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024091017/ownership.xml","form_type":"4"}},{"id":1459754,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":21667,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459753,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027."}],"balance_after":13349,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459752,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":1458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":11667,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":1458},"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459751,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":160,"price":153.48,"value":24556.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $153.04 to $153.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459750,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":582,"price":152.53,"value":88772.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $152.00 to $152.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21003,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459749,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":1106,"price":151.33,"value":167370.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.00 to $151.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21585,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459748,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":150.7,"value":150700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.00 to $150.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22691,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459747,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":110,"price":149.57,"value":16452.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.00 to $149.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23691,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459746,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":1083,"price":13.28,"value":14382.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":23801,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459745,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":66.1,"value":27563.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22718,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1459744,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T16:30:05.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":1458,"price":38.46,"value":56074.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22301,"source":{"system":"sec-edgar","filing":"0000950170-24-081567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024081567/ownership.xml","form_type":"4"}},{"id":1489892,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":1084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":22750,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1084},"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489891,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027."}],"balance_after":13766,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489890,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":1459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":13125,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":1459},"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489889,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":457,"price":135.97,"value":62138.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $135.37 to $136.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489888,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":152,"price":134.66,"value":20468.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $134.33 to $135.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21300,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489887,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":567,"price":133.67,"value":75790.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $133.31 to $134.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21452,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489886,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":921,"price":132.71,"value":122225.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $132.315 to $133.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22019,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489885,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":539,"price":131.87,"value":71077.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $131.30 to $132.295, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22940,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489884,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":219,"price":130.79,"value":28643.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $130.315 to $131.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23479,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489883,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":105,"price":129.92,"value":13641.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $129.30 to $130.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23698,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489882,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":1084,"price":13.28,"value":14395.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":23803,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489881,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":66.1,"value":27563.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22719,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1489880,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T17:11:43.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":1459,"price":38.46,"value":56113.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":22302,"source":{"system":"sec-edgar","filing":"0000950170-24-069423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024069423/ownership.xml","form_type":"4"}},{"id":1517338,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":11051,"price":105.71,"value":1168201.21,"ownership":{"direct":false,"nature":"By the Tamer Ibrahim Ahmed Khayal Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.50 to $105.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517337,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":123.66,"value":12366.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $123.64 to $123.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20843,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517336,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":444,"price":121.84,"value":54096.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $121.515 to $122.505, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20943,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517335,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":422,"price":121.21,"value":51150.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $120.52 to $121.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21387,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517334,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":1815,"price":119.96,"value":217727.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $119.51 to $120.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21809,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517333,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":1417,"price":119,"value":168623.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $118.51 to $119.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23624,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517332,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":759,"price":117.97,"value":89539.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $117.46 to $118.425, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":25041,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517331,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":326,"price":116.8,"value":38076.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $116.32 to $117.155, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":25800,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517330,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":113.16,"value":11316.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."}],"balance_after":26126,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517329,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":5313,"price":110,"value":584430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $110.00 to $110.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":26226,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517328,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":13078,"price":109.68,"value":1434395.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.00 to $109.855, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":31539,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}},{"id":1517327,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":82348,"kind":"person","name":"Khayal Tamer I","position":1,"cik":"0001430462","reported_name":"Khayal Tamer I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-14T18:00:20.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":1792,"price":108.35,"value":194163.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.89 to $108.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":44617,"source":{"system":"sec-edgar","filing":"0000950170-24-059829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430462/000095017024059829/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-03"}}],"next_cursor":"2024-05-14T18:00:20.000000Z,1517327"}